Shutterstock
Written by: Guillaume Wallart, CEO, CellQuest
Diagnostics Model Can Make Autologous Cell Therapy Manufacturing Work
Guillaume Wallart, CEO, CellQuest explores how diagnostics models can make autologous cell therapy manufacturing work in our latest EPM online insight.
Published:
|
4 min read
Last updated:
Sign up to our newsletter
The week's biggest stories from this industry, direct to your inbox.